ProCE Banner Activity

Approaches to CMV Immune Monitoring in Solid Organ Transplant Recipients

Clinical Thought

Here are the scenarios where I would consider CMV immune monitoring with CMV cell-mediated immunity assays to understand a patient’s risk of CMV infection, disease progression, and relapse post transplantation. 

Released: November 10, 2023

Share

Faculty

Raymund Razonable

Raymund Razonable, MD

Professor of Medicine
Division of Public Health, Infectious Diseases and Occupational Medicine
Mayo Clinic
Rochester, Minnesota 

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

Merck & Co., Inc., Rahway, NJ, USA

Disclosure

Primary Author

Raymund Razonable, MD

Professor of Medicine
Division of Public Health, Infectious Diseases and Occupational Medicine
Mayo Clinic
Rochester, Minnesota 

Raymund Razonable, MD: consultant/advisor/speaker: Novartis; researcher: Gilead, Regeneron, Roche; independent contractor: Allovir.